Log book

Patient 2050: Transformation axis and associated challenges

26 September 2019 | Alcim's articles

Predicting what the world of healthcare will look like in 2050 is a major challenge, yet the key trends in innovation combined with certain weaker signals suggest that the patient’s condition is likely to change over the next 30 years. In order to decipher the opportunities and challenges that will come along with the transformation […]

Read more

Maturation of Liquid Biopsy as a tool to optimize cancer treatment

1 August 2019 | Alcim's articles

Alcimed, an innovation & new business consulting firm, has explored the trends in the liquid biopsy field and discusses some of the challenges as players move from the Non-invasive Prenatal Testing (NIPT) market toward further validation in oncology. Liquid biopsy’s first application was in non-invasive prenatal testing with an explosive market penetration. Liquid biopsy has […]

Read more

Interventional oncology, a new weapon against cancer

30 July 2019 | Alcim's articles

As part of the demand for more personalized and less aggressive treatments, interventional oncology represents a major field of innovation for cancer treatment. While it makes it possible both to optimize the diagnosis and to expand the therapeutic arsenal, it faces obstacles in terms of funding and accessibility.  To mark the opening of a high-tech […]

Read more

Bioprinting, an upcoming revolution?

25 July 2019 | Alcim's articles

In April, researchers at Tel Aviv University succeeded in recreating a vascularized heart through 3D printing. Even if the organ was the size of a cherry, the progress is immense, and research is getting closer to the ultimate goal of reconstructing organs. The field of bioprinting is booming as many applications are being developed. Alcimed, […]

Read more